ION717 clinical trial completes patient enrolment

Author: Eric Minikel (translated by Joaquín Castilla) Ionis Pharmaceuticals has announced (see original letter) this morning that it has completed enrolment of PrProfile, its Phase 1/2a clinical trial of ION717, an ASO drug designed to reduce PrP levels in prion diseases. The study is now listed as "Active, without [...]

en_GBEnglish (UK)